Pre-Term Clinical Trial
Official title:
Low-birthweight Infant Feeding Exploration
Globally, 15% of all babies, amounting to 20 million infants each year, are born low birthweight (LBW), defined less than 2500 grams (5.5 lbs). Compared to normal weight infants, LBW infants are at higher risk of morbidity, mortality, and poor growth (Risnes et al 2011; Larroque et al 2001; WHO 2006). The main causes of LBW are preterm birth, intrauterine growth restriction (IUGR), or their combination. Unfortunately, there is a paucity of information around feeding practices and optimal feeding strategies for this population, particularly for LBW infants who struggle with breastfeeding or growth. This study hopes to address these gaps.
The Low-birthweight Infant Feeding Exploration (LIFE)(original grant 0-6 months of age) and the 6- month extension (6-12 months of age) will fill a critical data gap in the field of newborn care regarding vulnerability and feeding of LBW infants. The investigators aim to establish the background information required to set up and test the most efficient and feasible infant feeding strategies for LBW infants: first to support breastfeeding, and then to support infants who are nutritionally at risk in the first 6 month of life in low and middle income countries (LMIC). The investigators will explore all three infant feeding options currently included in the WHO guidelines for LBW infants (WHO 2011), namely mother's own milk (MOM), donor human milk (DHM), and breast milk substitute or formula (BMS), in that order. This work will provide much-needed evidence to inform infant feeding guidelines. In addition, this 6-month extension will allow for a more comprehensive exploration and understanding of feeding options for LBW infants from 6 to 12 months of age, accounting for timing of introduction of complementary liquids and foods, changes in feeding types, growth and health outcomes over the entire infancy period. This will contribute significantly and allow for high quality data to describe the burden of disease across sites. Specifically, we will be able to describe the following for LBW infants: - Growth trajectories from 0 to 12 months of age - Patterns and timing of complementary feeding and continued breastfeeding/breastmilk consumption - Common infant morbidities and timing of mortality - Maternal demographics, well-being and environmental factors affecting infant feeding and growth The overall study goal is to understand feeding options for LBW infants in LMIC settings, including current feeding practices, health outcomes, and potential interventions. The study will take place in four study sites located in three countries: Tanzania, Malawi, and India. Each study site will encompass 2 to 5 individual study facilities. The three study objectives under the goal include: 1. Understand the current practices and standard of care (SOC) for feeding LBW infants 2. Define and document the key outcomes (including growth, morbidity, and lack of success on MOM) for LBW infants under current practices 3. Assess the acceptability and feasibility of a system-level IYCF intervention and the proposed infant feeding options for LBW infants The investigators will also use the results of this work to design ways to support exclusive breastfeeding (including strategies for feeding with MOM), and to support other options, when mother's own milk (MOM) is unavailable or infants are nutritionally at risk. To do this, the investigators will engage in discussion and consensus-building activities among study staff and key stakeholders, using the collected study data to inform feasible, acceptable Infant and Young Child Feeding (IYCF) strategies for LBW infants that include specific options for those who are nutritionally at risk. The strategies will be tailored to the country as much as possible. A primary product for this later stage will be a white paper documenting key findings from the research and proposing feeding strategies for LBW infants in study sites. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04200807 -
Non-invasive Measurement of Neonatal Central and Peripheral Hemodynamics
|
||
Active, not recruiting |
NCT05282628 -
I-InTERACT Preterm
|
N/A | |
Recruiting |
NCT04717037 -
Olive Oil Massage Effect for Reduction of Preterm Sepsis (OMEPS)
|
Phase 2/Phase 3 | |
Completed |
NCT05017727 -
Closed-loop Oxygen Control in Ventilated Infants Born at or Near Term
|
||
Completed |
NCT04633551 -
Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes
|
N/A | |
Completed |
NCT04295395 -
Evaluation of the Brain and Renal Regional Oxygenation Using NIRS in Preterm Infants
|
||
Recruiting |
NCT05383586 -
MusicHyperBrain Study With Preterm Infants and Their Parents
|
N/A | |
Not yet recruiting |
NCT04812249 -
Effect of Co-morbidities on the Development of Oral Feeding Ability in Pre-term Infants
|
||
Recruiting |
NCT03966170 -
Citicoline as Neuroprotector in Preterm
|
Phase 3 | |
Completed |
NCT05863481 -
Obstetric Outcome in Pregnancies Treated With Laparoscopic Cerclage
|
||
Recruiting |
NCT06414655 -
Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China
|
||
Recruiting |
NCT05404594 -
Multimodal Approach to the Ontogenesis of Nociception in Very Preterm and Term Infants
|
N/A | |
Not yet recruiting |
NCT05188066 -
Study of Pregnancy Pathologies Associated With Placental Abnormalities
|
||
Not yet recruiting |
NCT05629910 -
NeO2Matic-Pilot Trial
|
N/A | |
Completed |
NCT04811872 -
Placental Transfusion Effect on Hemodynamics of Premature Newborns
|
Phase 2/Phase 3 | |
Completed |
NCT04785183 -
Antioxidant Effects of Melatonin in Preterm
|
N/A | |
Not yet recruiting |
NCT05243901 -
EPIPAGE 2 - 10-year Follow-up (RECONAI PROJECT)
|
||
Not yet recruiting |
NCT04333121 -
Modelling Weight Reference Centiles for Preterm Infants
|
||
Completed |
NCT04292015 -
Optos Versus Indirect Ophthalmoscopy for ROP Screening Examination (Optos vs BIO Study)
|
N/A | |
Not yet recruiting |
NCT04351425 -
Early Weaning of Preterm Newborn From Incubator to Cot at 1400 Grams
|
N/A |